Forty51 Ventures
Finance · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Engelgasse 119, Basel, Basel-City, 4052,...Website
www.forty51ventures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Forty51 Ventures
FORTY51 Ventures is a biotech venture creator focused on investing in early-stage biotech opportunities in Europe, particularly those with a clear path to clinical development. The company supports biotech entrepreneurs by providing hands-on assistance and leveraging decades of experience in the pharmaceutical industry. Their investment preferences span various therapeutic areas, including CNS, oncology, immunology, inflammation, fibrotic disorders, and ophthalmology. Founded in April 2022, FORTY51 Ventures aims to build exceptional biotech companies with first or best-in-class potential.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Forty51 Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Forty51 Ventures is spiking on competitors!
Earning: See what the market has to say on Forty51 Ventures recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Forty51 Ventures
Click to see if Forty51 Ventures had a recent Job posting/layoffs
Product Launch: Get notified when Forty51 Ventures launches new products
Funding: Get notified immidiatlly once Forty51 Ventures has new funding data
Check if Forty51 Ventures has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Forty51 Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Forty51 Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Forty51 Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Forty51 Ventures.
Forty51 Ventures Tech Stack
A closer look at the technologies used by Forty51 Ventures
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Forty51 Ventures News & Media
ALLEGRIA THERAPEUTICS SECURES USD 5.1 MILLION SEED EXTENSION FINANCING
BASEL, Switzerland, Dec. 11, 2025 /PRNewswire/ --Allegria Therapeutics (ALLEGRIA), a Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases, announced today the successful completion of a USD 5.1 million seed extension financing. The...ALLEGRIA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE PIPELINE OF NOVEL AND SELECTIVE THERAPEUTIC APPROACHES FOR MAST CELL-MEDIATED DISEASES
BASEL, Switzerland , May 6, 2024 /PRNewswire/ -- Allegria Therapeutics ("ALLEGRIA"), a Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases, announced today a Seed Financing of USD 3.5 Million by founding investor Forty51 Ventures....Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS118 to Treat Metabolic Obstructive Sleep Apnea
Company pursuing an advanced small molecule MOS118 (formerly known as AVE0118) discovered by Sanofi Experienced team with strong background in Metabolic Diseases and Obstructive Sleep Apnea Seed financing led by Forty51 Ventures BASEL, Switzerland, July 13, 2022 /PRNewswire/ -- Mosanna...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Forty51 Ventures
Sign Up For FreeTo access detailed company insights
FORTY51 Ventures is a biotech venture creator focused on investing in early-stage biotech opportunities in Europe, particularly those with a clear path to clinical development. The company supports biotech entrepreneurs by providing hands-on assistance and leveraging decades of experience in the pharmaceutical industry. Their investment preferences... Read More
